Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic growth factors.

M E Williams1, P J Quesenberry

  • 1Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville 22908.

Hematologic Pathology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust Bottom-Up Gold Filling of Deep Trenches and Gratings.

Journal of the Electrochemical Society·2023
Same author

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Solidification of Ni-Re Peritectic Alloys.

Metallurgical and materials transactions. A. Physical metallurgy and materials science·2020
Same author

Accelerated Bottom-Up Gold Filling of Metallized Trenches.

Journal of the Electrochemical Society·2020
Same author

Exploring the Limits of Bottom-Up Gold Filling to Fabricate Diffraction Gratings.

Journal of the Electrochemical Society·2020
Same author

An approach for the identification of exemplar sites for scaling up targeted field observations of benthic biogeochemistry in heterogeneous environments.

Biogeochemistry·2020

Hemolymphopoietic growth factors like erythropoietin, G-CSF, and GM-CSF are revolutionizing blood disorders and cancer care. While beneficial for anemia and neutropenia, their impact on cancer cure rates and potential tumor stimulation requires further clinical evaluation.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Hemolymphopoietic growth factors have significantly advanced understanding of blood cell development and immune responses.
  • Clinical translation of these growth factors has rapidly progressed, impacting various medical fields.

Purpose of the Study:

  • To review the clinical applications and implications of hemolymphopoietic growth factors, including erythropoietin, G-CSF, and GM-CSF.
  • To discuss the benefits and limitations of these factors in treating anemia, neutropenia, and as supportive care in cancer therapy.

Main Methods:

  • Review of current clinical applications and research findings on erythropoietin, G-CSF, and GM-CSF.
  • Analysis of their efficacy in managing anemia, neutropenia, and treatment toxicities.
  • Consideration of potential impact on cancer cure rates and tumor biology.

Related Experiment Videos

Main Results:

  • Erythropoietin is established for anemia treatment and shows promise in supportive cancer care and blood donation.
  • G-CSF and GM-CSF are FDA-approved for specific indications, effective in managing neutropenias and reducing chemoradiotherapy toxicity.
  • No current evidence demonstrates increased cure rates or survival with G-CSF or GM-CSF in malignancies.

Conclusions:

  • G-CSF and GM-CSF may allow for dose escalation or reduced toxicity of chemotherapy regimens.
  • The overall benefit of these growth factors in cancer treatment hinges on whether dose escalation improves cure rates.
  • Potential tumor growth stimulation by these cytokines, observed in vitro, requires thorough clinical investigation.